Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

microcephaly-brain defect-spasticity-hypernatremia syndrome News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

Research identifies bi-allelic GSPT1 variants linked to a syndromic neurodevelopmental disorder, which includes symptoms of intellectual disability and microcephaly. This discovery enhances understanding of genetic factors in rare neurodevelopmental conditions.

Children born with microcephaly due to congenital Zika virus infection encounter significant health and developmental challenges by 19-24 months of age. This highlights the ongoing need for support and resources for affected families.

CDC allocates nearly $184 million to combat Zika virus and its associated health risks, including microcephaly. This funding will support various states, territories, and universities in their efforts to protect public health.

A study reveals a four-fold increase in microcephaly cases in Colombia following the 2016 Zika virus outbreak, indicating that the risk is highest among pregnant women infected early in their pregnancy. This finding underscores the broader impact of Zika virus outbreaks beyond Brazil.

CDC researchers, alongside US and Brazilian teams, have documented cases of microcephaly onset after birth in infants with congenital Zika virus infection. This study highlights the ongoing neurological complications associated with Zika, emphasizing the need for continued surveillance.

CDC allocates $2.4 million to five jurisdictions, including Chicago and New York City, to improve systems for detecting microcephaly and other outcomes related to Zika virus infection. This funding aims to enhance public health responses to the ongoing challenges posed by Zika.

CDC allocates $16 million to states and territories to combat Zika virus and its associated risks, including microcephaly. This funding aims to enhance rapid case identification and response efforts.

CDC allocates nearly $60 million to states and territories to combat Zika virus disease and its associated health risks, including microcephaly. This funding aims to enhance protective measures against Zika infections.

CDC allocates $25 million to states and territories to bolster Zika virus preparedness and mitigate associated health risks, including microcephaly. This funding aims to enhance public health responses to prevent infection and its severe consequences.

The CDC has announced over $85 million in funding for U.S. states and territories to combat Zika virus and its associated health risks, including microcephaly. This funding aims to enhance local preparedness and response efforts against Zika infection.

CDC scientists confirm that Zika virus causes microcephaly and other severe fetal brain defects, solidifying the link between the virus and these critical health issues. This conclusion is based on a thorough review of existing evidence.

Not rare diseases news,news about your rare disease.